|
Nuvo products, based on its transdermal and immune technology platforms are marketed primarily through third parties in
order that we may focus on the development of additional drugs. Nuvo's partners can be viewed by geographic area.
Nuvo Research Inc. is actively seeking licensing and co-development partnerships for its current products and drug candidates.
Nuvo is also seeking to enter collaborative opportunities with partners wishing to develop transdermal medications using our expertise in transdermal formulation development.
| Interested parties should contact: |  |
| 
